Global RDC Drugs Market Growth (Status and Outlook) 2026-2032
The global RDC Drugs market size is predicted to grow from US$ 10490 million in 2025 to US$ 19640 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032.
RDC (Radiopharmaceutical Drug Conjugate) drugs represent a class of precision therapeutic or diagnostic agents formed by linking molecules capable of targeted recognition with radionuclides via chelators or chemical linkers. Their core mechanism relies on "targeted delivery combined with localized radioactive killing or imaging" to achieve highly selective treatment or visualization of tumors or specific lesions—such as in PSMA-targeted therapy for prostate cancer or the management of neuroendocrine tumors. This field is currently a key area of ??development in nuclear medicine and precision oncology.
In terms of the industry value chain, the upstream sector encompasses the production of medical radioisotopes, the supply of stable isotopes, the provision of chemical materials (chelators and linkers), and the R&D of targeting ligands. The midstream sector consists of companies dedicated to R&D and formulation, handling radionuclide labeling processes, quality control, GMP-compliant radiopharmaceutical preparation, and the logistics of cold-chain or decay-in-storage management. The downstream sector comprises hospital nuclear medicine departments, oncology centers, and PET/SPECT diagnostic and radiotherapy facilities, where patient administration, imaging, and therapeutic applications take place; this sector operates within a robust regulatory framework that imposes strict industry constraints.
Regarding future prospects, the RDC drug sector is in the early stages of a global boom, driven by the rising demand for precision oncology, the maturation of radionuclide supply chains, and the widespread adoption of the "theranostics" (combined diagnosis and therapy) model. Future growth is expected to stem from expanded indications for prostate cancer, neuroendocrine tumors, breast cancer, and other solid tumors, while alpha-radionuclide therapies promise to drive a new wave of technological advancement. Characterized by high barriers to entry, rapid growth, and high unit prices, the industry is expected to continue attracting major pharmaceutical companies and nuclear technology firms.
LPI (LP Information)' newest research report, the “RDC Drugs Industry Forecast” looks at past sales and reviews total world RDC Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected RDC Drugs sales for 2026 through 2032. With RDC Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RDC Drugs industry.
This Insight Report provides a comprehensive analysis of the global RDC Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on RDC Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global RDC Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RDC Drugs and breaks down the forecast by Target Ligand Types, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RDC Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of RDC Drugs market by product type, application, key players and key regions and countries.
RDC (Radiopharmaceutical Drug Conjugate) drugs represent a class of precision therapeutic or diagnostic agents formed by linking molecules capable of targeted recognition with radionuclides via chelators or chemical linkers. Their core mechanism relies on "targeted delivery combined with localized radioactive killing or imaging" to achieve highly selective treatment or visualization of tumors or specific lesions—such as in PSMA-targeted therapy for prostate cancer or the management of neuroendocrine tumors. This field is currently a key area of ??development in nuclear medicine and precision oncology.
In terms of the industry value chain, the upstream sector encompasses the production of medical radioisotopes, the supply of stable isotopes, the provision of chemical materials (chelators and linkers), and the R&D of targeting ligands. The midstream sector consists of companies dedicated to R&D and formulation, handling radionuclide labeling processes, quality control, GMP-compliant radiopharmaceutical preparation, and the logistics of cold-chain or decay-in-storage management. The downstream sector comprises hospital nuclear medicine departments, oncology centers, and PET/SPECT diagnostic and radiotherapy facilities, where patient administration, imaging, and therapeutic applications take place; this sector operates within a robust regulatory framework that imposes strict industry constraints.
Regarding future prospects, the RDC drug sector is in the early stages of a global boom, driven by the rising demand for precision oncology, the maturation of radionuclide supply chains, and the widespread adoption of the "theranostics" (combined diagnosis and therapy) model. Future growth is expected to stem from expanded indications for prostate cancer, neuroendocrine tumors, breast cancer, and other solid tumors, while alpha-radionuclide therapies promise to drive a new wave of technological advancement. Characterized by high barriers to entry, rapid growth, and high unit prices, the industry is expected to continue attracting major pharmaceutical companies and nuclear technology firms.
LPI (LP Information)' newest research report, the “RDC Drugs Industry Forecast” looks at past sales and reviews total world RDC Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected RDC Drugs sales for 2026 through 2032. With RDC Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RDC Drugs industry.
This Insight Report provides a comprehensive analysis of the global RDC Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on RDC Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global RDC Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RDC Drugs and breaks down the forecast by Target Ligand Types, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RDC Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of RDC Drugs market by product type, application, key players and key regions and countries.
Segmentation by Target Ligand Types:
- Antibody-Drug Conjugates (ARC)
- Peptide-Drug Conjugates (PRC)
- Small Molecule-Drug Conjugates (SMRC)
Segmentation by Medical Uses:
- Diagnostic RDCs
- Therapeutic RDCs
Segmentation by Therapeutic Radionuclide Properties:
- ?-Nuclear Therapy
- ?-Nuclear Therapy
Segmentation by Application:
- Prostate Cancer
- Neuroendocrine Tumors
- Liver Cancer
- Kidney Cancer
- Bone Metastases
- Others
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novartis
- Bayer
- AstraZeneca
- Eli Lilly
- Bristol-Myers Squibb
- Johnson & Johnson
- Grand Pharmaceutical Group
- China Isotope & Radiation Corporation
- Dongcheng Pharmaceutical
- Hengrui Medicine
- Xiantong Pharmaceutical
- Bivision
- SmartNuclide
- Full-Life Technologies
- Hexin (Suzhou) Pharmaceutical Technology Co., Ltd.
- Nuoyu Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global RDC Drugs Market Size (2021-2032)
2.1.2 RDC Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for RDC Drugs by Country/Region (2021, 2025 & 2032)
2.2 RDC Drugs Segment by Target Ligand Types
2.2.1 Antibody-Drug Conjugates (ARC)
2.2.2 Peptide-Drug Conjugates (PRC)
2.2.3 Small Molecule-Drug Conjugates (SMRC)
2.2.4 RDC Drugs Market Size by Target Ligand Types
2.2.4.1 RDC Drugs Market Size CAGR by Target Ligand Types (2021 VS 2025 VS 2032)
2.2.4.2 Global RDC Drugs Market Size Market Share by Target Ligand Types (2021-2026)
2.3 RDC Drugs Segment by Medical Uses
2.3.1 Diagnostic RDCs
2.3.2 Therapeutic RDCs
2.3.3 RDC Drugs Market Size by Medical Uses
2.3.3.1 RDC Drugs Market Size CAGR by Medical Uses (2021 VS 2025 VS 2032)
2.3.3.2 Global RDC Drugs Market Size Market Share by Medical Uses (2021-2026)
2.4 RDC Drugs Segment by Therapeutic Radionuclide Properties
2.4.1 ?-Nuclear Therapy
2.4.2 ?-Nuclear Therapy
2.4.3 RDC Drugs Market Size by Therapeutic Radionuclide Properties
2.4.3.1 RDC Drugs Market Size CAGR by Therapeutic Radionuclide Properties (2021 VS 2025 VS 2032)
2.4.3.2 Global RDC Drugs Market Size Market Share by Therapeutic Radionuclide Properties (2021-2026)
2.5 RDC Drugs Segment by Application
2.5.1 Prostate Cancer
2.5.2 Neuroendocrine Tumors
2.5.3 Liver Cancer
2.5.4 Kidney Cancer
2.5.5 Bone Metastases
2.5.6 Others
2.5.7 RDC Drugs Market Size by Application
2.5.7.1 RDC Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.7.2 Global RDC Drugs Market Size Market Share by Application (2021-2026)
3 RDC DRUGS MARKET SIZE BY PLAYER
3.1 RDC Drugs Market Size Market Share by Player
3.1.1 Global RDC Drugs Revenue by Player (2021-2026)
3.1.2 Global RDC Drugs Revenue Market Share by Player (2021-2026)
3.2 Global RDC Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RDC DRUGS BY REGION
4.1 RDC Drugs Market Size by Region (2021-2026)
4.2 Global RDC Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas RDC Drugs Market Size Growth (2021-2026)
4.4 APAC RDC Drugs Market Size Growth (2021-2026)
4.5 Europe RDC Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa RDC Drugs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas RDC Drugs Market Size by Country (2021-2026)
5.2 Americas RDC Drugs Market Size by Target Ligand Types (2021-2026)
5.3 Americas RDC Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RDC Drugs Market Size by Region (2021-2026)
6.2 APAC RDC Drugs Market Size by Target Ligand Types (2021-2026)
6.3 APAC RDC Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe RDC Drugs Market Size by Country (2021-2026)
7.2 Europe RDC Drugs Market Size by Target Ligand Types (2021-2026)
7.3 Europe RDC Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa RDC Drugs by Region (2021-2026)
8.2 Middle East & Africa RDC Drugs Market Size by Target Ligand Types (2021-2026)
8.3 Middle East & Africa RDC Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RDC DRUGS MARKET FORECAST
10.1 Global RDC Drugs Forecast by Region (2027-2032)
10.1.1 Global RDC Drugs Forecast by Region (2027-2032)
10.1.2 Americas RDC Drugs Forecast
10.1.3 APAC RDC Drugs Forecast
10.1.4 Europe RDC Drugs Forecast
10.1.5 Middle East & Africa RDC Drugs Forecast
10.2 Americas RDC Drugs Forecast by Country (2027-2032)
10.2.1 United States Market RDC Drugs Forecast
10.2.2 Canada Market RDC Drugs Forecast
10.2.3 Mexico Market RDC Drugs Forecast
10.2.4 Brazil Market RDC Drugs Forecast
10.3 APAC RDC Drugs Forecast by Region (2027-2032)
10.3.1 China RDC Drugs Market Forecast
10.3.2 Japan Market RDC Drugs Forecast
10.3.3 Korea Market RDC Drugs Forecast
10.3.4 Southeast Asia Market RDC Drugs Forecast
10.3.5 India Market RDC Drugs Forecast
10.3.6 Australia Market RDC Drugs Forecast
10.4 Europe RDC Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market RDC Drugs Forecast
10.4.2 France Market RDC Drugs Forecast
10.4.3 UK Market RDC Drugs Forecast
10.4.4 Italy Market RDC Drugs Forecast
10.4.5 Russia Market RDC Drugs Forecast
10.5 Middle East & Africa RDC Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market RDC Drugs Forecast
10.5.2 South Africa Market RDC Drugs Forecast
10.5.3 Israel Market RDC Drugs Forecast
10.5.4 Turkey Market RDC Drugs Forecast
10.6 Global RDC Drugs Forecast by Target Ligand Types (2027-2032)
10.7 Global RDC Drugs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market RDC Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis RDC Drugs Product Offered
11.1.3 Novartis RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer RDC Drugs Product Offered
11.2.3 Bayer RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca RDC Drugs Product Offered
11.3.3 AstraZeneca RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Information
11.4.2 Eli Lilly RDC Drugs Product Offered
11.4.3 Eli Lilly RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Eli Lilly Main Business Overview
11.4.5 Eli Lilly Latest Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Information
11.5.2 Bristol-Myers Squibb RDC Drugs Product Offered
11.5.3 Bristol-Myers Squibb RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Bristol-Myers Squibb Main Business Overview
11.5.5 Bristol-Myers Squibb Latest Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson RDC Drugs Product Offered
11.6.3 Johnson & Johnson RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Johnson & Johnson Main Business Overview
11.6.5 Johnson & Johnson Latest Developments
11.7 Grand Pharmaceutical Group
11.7.1 Grand Pharmaceutical Group Company Information
11.7.2 Grand Pharmaceutical Group RDC Drugs Product Offered
11.7.3 Grand Pharmaceutical Group RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Grand Pharmaceutical Group Main Business Overview
11.7.5 Grand Pharmaceutical Group Latest Developments
11.8 China Isotope & Radiation Corporation
11.8.1 China Isotope & Radiation Corporation Company Information
11.8.2 China Isotope & Radiation Corporation RDC Drugs Product Offered
11.8.3 China Isotope & Radiation Corporation RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 China Isotope & Radiation Corporation Main Business Overview
11.8.5 China Isotope & Radiation Corporation Latest Developments
11.9 Dongcheng Pharmaceutical
11.9.1 Dongcheng Pharmaceutical Company Information
11.9.2 Dongcheng Pharmaceutical RDC Drugs Product Offered
11.9.3 Dongcheng Pharmaceutical RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Dongcheng Pharmaceutical Main Business Overview
11.9.5 Dongcheng Pharmaceutical Latest Developments
11.10 Hengrui Medicine
11.10.1 Hengrui Medicine Company Information
11.10.2 Hengrui Medicine RDC Drugs Product Offered
11.10.3 Hengrui Medicine RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Hengrui Medicine Main Business Overview
11.10.5 Hengrui Medicine Latest Developments
11.11 Xiantong Pharmaceutical
11.11.1 Xiantong Pharmaceutical Company Information
11.11.2 Xiantong Pharmaceutical RDC Drugs Product Offered
11.11.3 Xiantong Pharmaceutical RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Xiantong Pharmaceutical Main Business Overview
11.11.5 Xiantong Pharmaceutical Latest Developments
11.12 Bivision
11.12.1 Bivision Company Information
11.12.2 Bivision RDC Drugs Product Offered
11.12.3 Bivision RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Bivision Main Business Overview
11.12.5 Bivision Latest Developments
11.13 SmartNuclide
11.13.1 SmartNuclide Company Information
11.13.2 SmartNuclide RDC Drugs Product Offered
11.13.3 SmartNuclide RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 SmartNuclide Main Business Overview
11.13.5 SmartNuclide Latest Developments
11.14 Full-Life Technologies
11.14.1 Full-Life Technologies Company Information
11.14.2 Full-Life Technologies RDC Drugs Product Offered
11.14.3 Full-Life Technologies RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Full-Life Technologies Main Business Overview
11.14.5 Full-Life Technologies Latest Developments
11.15 Hexin (Suzhou) Pharmaceutical Technology Co., Ltd.
11.15.1 Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. Company Information
11.15.2 Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. RDC Drugs Product Offered
11.15.3 Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. Main Business Overview
11.15.5 Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. Latest Developments
11.16 Nuoyu Pharmaceutical
11.16.1 Nuoyu Pharmaceutical Company Information
11.16.2 Nuoyu Pharmaceutical RDC Drugs Product Offered
11.16.3 Nuoyu Pharmaceutical RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Nuoyu Pharmaceutical Main Business Overview
11.16.5 Nuoyu Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global RDC Drugs Market Size (2021-2032)
2.1.2 RDC Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for RDC Drugs by Country/Region (2021, 2025 & 2032)
2.2 RDC Drugs Segment by Target Ligand Types
2.2.1 Antibody-Drug Conjugates (ARC)
2.2.2 Peptide-Drug Conjugates (PRC)
2.2.3 Small Molecule-Drug Conjugates (SMRC)
2.2.4 RDC Drugs Market Size by Target Ligand Types
2.2.4.1 RDC Drugs Market Size CAGR by Target Ligand Types (2021 VS 2025 VS 2032)
2.2.4.2 Global RDC Drugs Market Size Market Share by Target Ligand Types (2021-2026)
2.3 RDC Drugs Segment by Medical Uses
2.3.1 Diagnostic RDCs
2.3.2 Therapeutic RDCs
2.3.3 RDC Drugs Market Size by Medical Uses
2.3.3.1 RDC Drugs Market Size CAGR by Medical Uses (2021 VS 2025 VS 2032)
2.3.3.2 Global RDC Drugs Market Size Market Share by Medical Uses (2021-2026)
2.4 RDC Drugs Segment by Therapeutic Radionuclide Properties
2.4.1 ?-Nuclear Therapy
2.4.2 ?-Nuclear Therapy
2.4.3 RDC Drugs Market Size by Therapeutic Radionuclide Properties
2.4.3.1 RDC Drugs Market Size CAGR by Therapeutic Radionuclide Properties (2021 VS 2025 VS 2032)
2.4.3.2 Global RDC Drugs Market Size Market Share by Therapeutic Radionuclide Properties (2021-2026)
2.5 RDC Drugs Segment by Application
2.5.1 Prostate Cancer
2.5.2 Neuroendocrine Tumors
2.5.3 Liver Cancer
2.5.4 Kidney Cancer
2.5.5 Bone Metastases
2.5.6 Others
2.5.7 RDC Drugs Market Size by Application
2.5.7.1 RDC Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.5.7.2 Global RDC Drugs Market Size Market Share by Application (2021-2026)
3 RDC DRUGS MARKET SIZE BY PLAYER
3.1 RDC Drugs Market Size Market Share by Player
3.1.1 Global RDC Drugs Revenue by Player (2021-2026)
3.1.2 Global RDC Drugs Revenue Market Share by Player (2021-2026)
3.2 Global RDC Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 RDC DRUGS BY REGION
4.1 RDC Drugs Market Size by Region (2021-2026)
4.2 Global RDC Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas RDC Drugs Market Size Growth (2021-2026)
4.4 APAC RDC Drugs Market Size Growth (2021-2026)
4.5 Europe RDC Drugs Market Size Growth (2021-2026)
4.6 Middle East & Africa RDC Drugs Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas RDC Drugs Market Size by Country (2021-2026)
5.2 Americas RDC Drugs Market Size by Target Ligand Types (2021-2026)
5.3 Americas RDC Drugs Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RDC Drugs Market Size by Region (2021-2026)
6.2 APAC RDC Drugs Market Size by Target Ligand Types (2021-2026)
6.3 APAC RDC Drugs Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe RDC Drugs Market Size by Country (2021-2026)
7.2 Europe RDC Drugs Market Size by Target Ligand Types (2021-2026)
7.3 Europe RDC Drugs Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa RDC Drugs by Region (2021-2026)
8.2 Middle East & Africa RDC Drugs Market Size by Target Ligand Types (2021-2026)
8.3 Middle East & Africa RDC Drugs Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL RDC DRUGS MARKET FORECAST
10.1 Global RDC Drugs Forecast by Region (2027-2032)
10.1.1 Global RDC Drugs Forecast by Region (2027-2032)
10.1.2 Americas RDC Drugs Forecast
10.1.3 APAC RDC Drugs Forecast
10.1.4 Europe RDC Drugs Forecast
10.1.5 Middle East & Africa RDC Drugs Forecast
10.2 Americas RDC Drugs Forecast by Country (2027-2032)
10.2.1 United States Market RDC Drugs Forecast
10.2.2 Canada Market RDC Drugs Forecast
10.2.3 Mexico Market RDC Drugs Forecast
10.2.4 Brazil Market RDC Drugs Forecast
10.3 APAC RDC Drugs Forecast by Region (2027-2032)
10.3.1 China RDC Drugs Market Forecast
10.3.2 Japan Market RDC Drugs Forecast
10.3.3 Korea Market RDC Drugs Forecast
10.3.4 Southeast Asia Market RDC Drugs Forecast
10.3.5 India Market RDC Drugs Forecast
10.3.6 Australia Market RDC Drugs Forecast
10.4 Europe RDC Drugs Forecast by Country (2027-2032)
10.4.1 Germany Market RDC Drugs Forecast
10.4.2 France Market RDC Drugs Forecast
10.4.3 UK Market RDC Drugs Forecast
10.4.4 Italy Market RDC Drugs Forecast
10.4.5 Russia Market RDC Drugs Forecast
10.5 Middle East & Africa RDC Drugs Forecast by Region (2027-2032)
10.5.1 Egypt Market RDC Drugs Forecast
10.5.2 South Africa Market RDC Drugs Forecast
10.5.3 Israel Market RDC Drugs Forecast
10.5.4 Turkey Market RDC Drugs Forecast
10.6 Global RDC Drugs Forecast by Target Ligand Types (2027-2032)
10.7 Global RDC Drugs Forecast by Application (2027-2032)
10.7.1 GCC Countries Market RDC Drugs Forecast
11 KEY PLAYERS ANALYSIS
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis RDC Drugs Product Offered
11.1.3 Novartis RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Novartis Main Business Overview
11.1.5 Novartis Latest Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer RDC Drugs Product Offered
11.2.3 Bayer RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Bayer Main Business Overview
11.2.5 Bayer Latest Developments
11.3 AstraZeneca
11.3.1 AstraZeneca Company Information
11.3.2 AstraZeneca RDC Drugs Product Offered
11.3.3 AstraZeneca RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 AstraZeneca Main Business Overview
11.3.5 AstraZeneca Latest Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Company Information
11.4.2 Eli Lilly RDC Drugs Product Offered
11.4.3 Eli Lilly RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Eli Lilly Main Business Overview
11.4.5 Eli Lilly Latest Developments
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Information
11.5.2 Bristol-Myers Squibb RDC Drugs Product Offered
11.5.3 Bristol-Myers Squibb RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Bristol-Myers Squibb Main Business Overview
11.5.5 Bristol-Myers Squibb Latest Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson RDC Drugs Product Offered
11.6.3 Johnson & Johnson RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Johnson & Johnson Main Business Overview
11.6.5 Johnson & Johnson Latest Developments
11.7 Grand Pharmaceutical Group
11.7.1 Grand Pharmaceutical Group Company Information
11.7.2 Grand Pharmaceutical Group RDC Drugs Product Offered
11.7.3 Grand Pharmaceutical Group RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Grand Pharmaceutical Group Main Business Overview
11.7.5 Grand Pharmaceutical Group Latest Developments
11.8 China Isotope & Radiation Corporation
11.8.1 China Isotope & Radiation Corporation Company Information
11.8.2 China Isotope & Radiation Corporation RDC Drugs Product Offered
11.8.3 China Isotope & Radiation Corporation RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 China Isotope & Radiation Corporation Main Business Overview
11.8.5 China Isotope & Radiation Corporation Latest Developments
11.9 Dongcheng Pharmaceutical
11.9.1 Dongcheng Pharmaceutical Company Information
11.9.2 Dongcheng Pharmaceutical RDC Drugs Product Offered
11.9.3 Dongcheng Pharmaceutical RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Dongcheng Pharmaceutical Main Business Overview
11.9.5 Dongcheng Pharmaceutical Latest Developments
11.10 Hengrui Medicine
11.10.1 Hengrui Medicine Company Information
11.10.2 Hengrui Medicine RDC Drugs Product Offered
11.10.3 Hengrui Medicine RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Hengrui Medicine Main Business Overview
11.10.5 Hengrui Medicine Latest Developments
11.11 Xiantong Pharmaceutical
11.11.1 Xiantong Pharmaceutical Company Information
11.11.2 Xiantong Pharmaceutical RDC Drugs Product Offered
11.11.3 Xiantong Pharmaceutical RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Xiantong Pharmaceutical Main Business Overview
11.11.5 Xiantong Pharmaceutical Latest Developments
11.12 Bivision
11.12.1 Bivision Company Information
11.12.2 Bivision RDC Drugs Product Offered
11.12.3 Bivision RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Bivision Main Business Overview
11.12.5 Bivision Latest Developments
11.13 SmartNuclide
11.13.1 SmartNuclide Company Information
11.13.2 SmartNuclide RDC Drugs Product Offered
11.13.3 SmartNuclide RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 SmartNuclide Main Business Overview
11.13.5 SmartNuclide Latest Developments
11.14 Full-Life Technologies
11.14.1 Full-Life Technologies Company Information
11.14.2 Full-Life Technologies RDC Drugs Product Offered
11.14.3 Full-Life Technologies RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Full-Life Technologies Main Business Overview
11.14.5 Full-Life Technologies Latest Developments
11.15 Hexin (Suzhou) Pharmaceutical Technology Co., Ltd.
11.15.1 Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. Company Information
11.15.2 Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. RDC Drugs Product Offered
11.15.3 Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. Main Business Overview
11.15.5 Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. Latest Developments
11.16 Nuoyu Pharmaceutical
11.16.1 Nuoyu Pharmaceutical Company Information
11.16.2 Nuoyu Pharmaceutical RDC Drugs Product Offered
11.16.3 Nuoyu Pharmaceutical RDC Drugs Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Nuoyu Pharmaceutical Main Business Overview
11.16.5 Nuoyu Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. RDC Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. RDC Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Antibody-Drug Conjugates (ARC)
Table 4. Major Players of Peptide-Drug Conjugates (PRC)
Table 5. Major Players of Small Molecule-Drug Conjugates (SMRC)
Table 6. RDC Drugs Market Size CAGR by Target Ligand Types (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global RDC Drugs Market Size by Target Ligand Types (2021-2026) & ($ millions)
Table 8. Global RDC Drugs Market Size Market Share by Target Ligand Types (2021-2026)
Table 9. Major Players of Diagnostic RDCs
Table 10. Major Players of Therapeutic RDCs
Table 11. RDC Drugs Market Size CAGR by Medical Uses (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global RDC Drugs Market Size by Medical Uses (2021-2026) & ($ millions)
Table 13. Global RDC Drugs Market Size Market Share by Medical Uses (2021-2026)
Table 14. Major Players of ?-Nuclear Therapy
Table 15. Major Players of ?-Nuclear Therapy
Table 16. RDC Drugs Market Size CAGR by Therapeutic Radionuclide Properties (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global RDC Drugs Market Size by Therapeutic Radionuclide Properties (2021-2026) & ($ millions)
Table 18. Global RDC Drugs Market Size Market Share by Therapeutic Radionuclide Properties (2021-2026)
Table 19. RDC Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global RDC Drugs Market Size by Application (2021-2026) & ($ millions)
Table 21. Global RDC Drugs Market Size Market Share by Application (2021-2026)
Table 22. Global RDC Drugs Revenue by Player (2021-2026) & ($ millions)
Table 23. Global RDC Drugs Revenue Market Share by Player (2021-2026)
Table 24. RDC Drugs Key Players Head office and Products Offered
Table 25. RDC Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global RDC Drugs Market Size by Region (2021-2026) & ($ millions)
Table 29. Global RDC Drugs Market Size Market Share by Region (2021-2026)
Table 30. Global RDC Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 31. Global RDC Drugs Revenue Market Share by Country/Region (2021-2026)
Table 32. Americas RDC Drugs Market Size by Country (2021-2026) & ($ millions)
Table 33. Americas RDC Drugs Market Size Market Share by Country (2021-2026)
Table 34. Americas RDC Drugs Market Size by Target Ligand Types (2021-2026) & ($ millions)
Table 35. Americas RDC Drugs Market Size Market Share by Target Ligand Types (2021-2026)
Table 36. Americas RDC Drugs Market Size by Application (2021-2026) & ($ millions)
Table 37. Americas RDC Drugs Market Size Market Share by Application (2021-2026)
Table 38. APAC RDC Drugs Market Size by Region (2021-2026) & ($ millions)
Table 39. APAC RDC Drugs Market Size Market Share by Region (2021-2026)
Table 40. APAC RDC Drugs Market Size by Target Ligand Types (2021-2026) & ($ millions)
Table 41. APAC RDC Drugs Market Size by Application (2021-2026) & ($ millions)
Table 42. Europe RDC Drugs Market Size by Country (2021-2026) & ($ millions)
Table 43. Europe RDC Drugs Market Size Market Share by Country (2021-2026)
Table 44. Europe RDC Drugs Market Size by Target Ligand Types (2021-2026) & ($ millions)
Table 45. Europe RDC Drugs Market Size by Application (2021-2026) & ($ millions)
Table 46. Middle East & Africa RDC Drugs Market Size by Region (2021-2026) & ($ millions)
Table 47. Middle East & Africa RDC Drugs Market Size by Target Ligand Types (2021-2026) & ($ millions)
Table 48. Middle East & Africa RDC Drugs Market Size by Application (2021-2026) & ($ millions)
Table 49. Key Market Drivers & Growth Opportunities of RDC Drugs
Table 50. Key Market Challenges & Risks of RDC Drugs
Table 51. Key Industry Trends of RDC Drugs
Table 52. Global RDC Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 53. Global RDC Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 54. Global RDC Drugs Market Size Forecast by Target Ligand Types (2027-2032) & ($ millions)
Table 55. Global RDC Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 56. Novartis Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 57. Novartis RDC Drugs Product Offered
Table 58. Novartis RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Novartis Main Business
Table 60. Novartis Latest Developments
Table 61. Bayer Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 62. Bayer RDC Drugs Product Offered
Table 63. Bayer RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Bayer Main Business
Table 65. Bayer Latest Developments
Table 66. AstraZeneca Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 67. AstraZeneca RDC Drugs Product Offered
Table 68. AstraZeneca RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. AstraZeneca Main Business
Table 70. AstraZeneca Latest Developments
Table 71. Eli Lilly Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 72. Eli Lilly RDC Drugs Product Offered
Table 73. Eli Lilly RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Eli Lilly Main Business
Table 75. Eli Lilly Latest Developments
Table 76. Bristol-Myers Squibb Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 77. Bristol-Myers Squibb RDC Drugs Product Offered
Table 78. Bristol-Myers Squibb RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Bristol-Myers Squibb Main Business
Table 80. Bristol-Myers Squibb Latest Developments
Table 81. Johnson & Johnson Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 82. Johnson & Johnson RDC Drugs Product Offered
Table 83. Johnson & Johnson RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Johnson & Johnson Main Business
Table 85. Johnson & Johnson Latest Developments
Table 86. Grand Pharmaceutical Group Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 87. Grand Pharmaceutical Group RDC Drugs Product Offered
Table 88. Grand Pharmaceutical Group RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Grand Pharmaceutical Group Main Business
Table 90. Grand Pharmaceutical Group Latest Developments
Table 91. China Isotope & Radiation Corporation Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 92. China Isotope & Radiation Corporation RDC Drugs Product Offered
Table 93. China Isotope & Radiation Corporation RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. China Isotope & Radiation Corporation Main Business
Table 95. China Isotope & Radiation Corporation Latest Developments
Table 96. Dongcheng Pharmaceutical Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 97. Dongcheng Pharmaceutical RDC Drugs Product Offered
Table 98. Dongcheng Pharmaceutical RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Dongcheng Pharmaceutical Main Business
Table 100. Dongcheng Pharmaceutical Latest Developments
Table 101. Hengrui Medicine Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 102. Hengrui Medicine RDC Drugs Product Offered
Table 103. Hengrui Medicine RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Hengrui Medicine Main Business
Table 105. Hengrui Medicine Latest Developments
Table 106. Xiantong Pharmaceutical Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 107. Xiantong Pharmaceutical RDC Drugs Product Offered
Table 108. Xiantong Pharmaceutical RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Xiantong Pharmaceutical Main Business
Table 110. Xiantong Pharmaceutical Latest Developments
Table 111. Bivision Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 112. Bivision RDC Drugs Product Offered
Table 113. Bivision RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Bivision Main Business
Table 115. Bivision Latest Developments
Table 116. SmartNuclide Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 117. SmartNuclide RDC Drugs Product Offered
Table 118. SmartNuclide RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. SmartNuclide Main Business
Table 120. SmartNuclide Latest Developments
Table 121. Full-Life Technologies Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 122. Full-Life Technologies RDC Drugs Product Offered
Table 123. Full-Life Technologies RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Full-Life Technologies Main Business
Table 125. Full-Life Technologies Latest Developments
Table 126. Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 127. Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. RDC Drugs Product Offered
Table 128. Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. Main Business
Table 130. Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. Latest Developments
Table 131. Nuoyu Pharmaceutical Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 132. Nuoyu Pharmaceutical RDC Drugs Product Offered
Table 133. Nuoyu Pharmaceutical RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Nuoyu Pharmaceutical Main Business
Table 135. Nuoyu Pharmaceutical Latest Developments
Table 1. RDC Drugs Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. RDC Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Antibody-Drug Conjugates (ARC)
Table 4. Major Players of Peptide-Drug Conjugates (PRC)
Table 5. Major Players of Small Molecule-Drug Conjugates (SMRC)
Table 6. RDC Drugs Market Size CAGR by Target Ligand Types (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global RDC Drugs Market Size by Target Ligand Types (2021-2026) & ($ millions)
Table 8. Global RDC Drugs Market Size Market Share by Target Ligand Types (2021-2026)
Table 9. Major Players of Diagnostic RDCs
Table 10. Major Players of Therapeutic RDCs
Table 11. RDC Drugs Market Size CAGR by Medical Uses (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global RDC Drugs Market Size by Medical Uses (2021-2026) & ($ millions)
Table 13. Global RDC Drugs Market Size Market Share by Medical Uses (2021-2026)
Table 14. Major Players of ?-Nuclear Therapy
Table 15. Major Players of ?-Nuclear Therapy
Table 16. RDC Drugs Market Size CAGR by Therapeutic Radionuclide Properties (2021 VS 2025 VS 2032) & ($ millions)
Table 17. Global RDC Drugs Market Size by Therapeutic Radionuclide Properties (2021-2026) & ($ millions)
Table 18. Global RDC Drugs Market Size Market Share by Therapeutic Radionuclide Properties (2021-2026)
Table 19. RDC Drugs Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 20. Global RDC Drugs Market Size by Application (2021-2026) & ($ millions)
Table 21. Global RDC Drugs Market Size Market Share by Application (2021-2026)
Table 22. Global RDC Drugs Revenue by Player (2021-2026) & ($ millions)
Table 23. Global RDC Drugs Revenue Market Share by Player (2021-2026)
Table 24. RDC Drugs Key Players Head office and Products Offered
Table 25. RDC Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global RDC Drugs Market Size by Region (2021-2026) & ($ millions)
Table 29. Global RDC Drugs Market Size Market Share by Region (2021-2026)
Table 30. Global RDC Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 31. Global RDC Drugs Revenue Market Share by Country/Region (2021-2026)
Table 32. Americas RDC Drugs Market Size by Country (2021-2026) & ($ millions)
Table 33. Americas RDC Drugs Market Size Market Share by Country (2021-2026)
Table 34. Americas RDC Drugs Market Size by Target Ligand Types (2021-2026) & ($ millions)
Table 35. Americas RDC Drugs Market Size Market Share by Target Ligand Types (2021-2026)
Table 36. Americas RDC Drugs Market Size by Application (2021-2026) & ($ millions)
Table 37. Americas RDC Drugs Market Size Market Share by Application (2021-2026)
Table 38. APAC RDC Drugs Market Size by Region (2021-2026) & ($ millions)
Table 39. APAC RDC Drugs Market Size Market Share by Region (2021-2026)
Table 40. APAC RDC Drugs Market Size by Target Ligand Types (2021-2026) & ($ millions)
Table 41. APAC RDC Drugs Market Size by Application (2021-2026) & ($ millions)
Table 42. Europe RDC Drugs Market Size by Country (2021-2026) & ($ millions)
Table 43. Europe RDC Drugs Market Size Market Share by Country (2021-2026)
Table 44. Europe RDC Drugs Market Size by Target Ligand Types (2021-2026) & ($ millions)
Table 45. Europe RDC Drugs Market Size by Application (2021-2026) & ($ millions)
Table 46. Middle East & Africa RDC Drugs Market Size by Region (2021-2026) & ($ millions)
Table 47. Middle East & Africa RDC Drugs Market Size by Target Ligand Types (2021-2026) & ($ millions)
Table 48. Middle East & Africa RDC Drugs Market Size by Application (2021-2026) & ($ millions)
Table 49. Key Market Drivers & Growth Opportunities of RDC Drugs
Table 50. Key Market Challenges & Risks of RDC Drugs
Table 51. Key Industry Trends of RDC Drugs
Table 52. Global RDC Drugs Market Size Forecast by Region (2027-2032) & ($ millions)
Table 53. Global RDC Drugs Market Size Market Share Forecast by Region (2027-2032)
Table 54. Global RDC Drugs Market Size Forecast by Target Ligand Types (2027-2032) & ($ millions)
Table 55. Global RDC Drugs Market Size Forecast by Application (2027-2032) & ($ millions)
Table 56. Novartis Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 57. Novartis RDC Drugs Product Offered
Table 58. Novartis RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Novartis Main Business
Table 60. Novartis Latest Developments
Table 61. Bayer Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 62. Bayer RDC Drugs Product Offered
Table 63. Bayer RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Bayer Main Business
Table 65. Bayer Latest Developments
Table 66. AstraZeneca Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 67. AstraZeneca RDC Drugs Product Offered
Table 68. AstraZeneca RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. AstraZeneca Main Business
Table 70. AstraZeneca Latest Developments
Table 71. Eli Lilly Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 72. Eli Lilly RDC Drugs Product Offered
Table 73. Eli Lilly RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Eli Lilly Main Business
Table 75. Eli Lilly Latest Developments
Table 76. Bristol-Myers Squibb Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 77. Bristol-Myers Squibb RDC Drugs Product Offered
Table 78. Bristol-Myers Squibb RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Bristol-Myers Squibb Main Business
Table 80. Bristol-Myers Squibb Latest Developments
Table 81. Johnson & Johnson Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 82. Johnson & Johnson RDC Drugs Product Offered
Table 83. Johnson & Johnson RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Johnson & Johnson Main Business
Table 85. Johnson & Johnson Latest Developments
Table 86. Grand Pharmaceutical Group Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 87. Grand Pharmaceutical Group RDC Drugs Product Offered
Table 88. Grand Pharmaceutical Group RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Grand Pharmaceutical Group Main Business
Table 90. Grand Pharmaceutical Group Latest Developments
Table 91. China Isotope & Radiation Corporation Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 92. China Isotope & Radiation Corporation RDC Drugs Product Offered
Table 93. China Isotope & Radiation Corporation RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. China Isotope & Radiation Corporation Main Business
Table 95. China Isotope & Radiation Corporation Latest Developments
Table 96. Dongcheng Pharmaceutical Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 97. Dongcheng Pharmaceutical RDC Drugs Product Offered
Table 98. Dongcheng Pharmaceutical RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Dongcheng Pharmaceutical Main Business
Table 100. Dongcheng Pharmaceutical Latest Developments
Table 101. Hengrui Medicine Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 102. Hengrui Medicine RDC Drugs Product Offered
Table 103. Hengrui Medicine RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Hengrui Medicine Main Business
Table 105. Hengrui Medicine Latest Developments
Table 106. Xiantong Pharmaceutical Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 107. Xiantong Pharmaceutical RDC Drugs Product Offered
Table 108. Xiantong Pharmaceutical RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. Xiantong Pharmaceutical Main Business
Table 110. Xiantong Pharmaceutical Latest Developments
Table 111. Bivision Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 112. Bivision RDC Drugs Product Offered
Table 113. Bivision RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 114. Bivision Main Business
Table 115. Bivision Latest Developments
Table 116. SmartNuclide Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 117. SmartNuclide RDC Drugs Product Offered
Table 118. SmartNuclide RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 119. SmartNuclide Main Business
Table 120. SmartNuclide Latest Developments
Table 121. Full-Life Technologies Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 122. Full-Life Technologies RDC Drugs Product Offered
Table 123. Full-Life Technologies RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 124. Full-Life Technologies Main Business
Table 125. Full-Life Technologies Latest Developments
Table 126. Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 127. Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. RDC Drugs Product Offered
Table 128. Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 129. Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. Main Business
Table 130. Hexin (Suzhou) Pharmaceutical Technology Co., Ltd. Latest Developments
Table 131. Nuoyu Pharmaceutical Details, Company Type, RDC Drugs Area Served and Its Competitors
Table 132. Nuoyu Pharmaceutical RDC Drugs Product Offered
Table 133. Nuoyu Pharmaceutical RDC Drugs Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 134. Nuoyu Pharmaceutical Main Business
Table 135. Nuoyu Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. RDC Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RDC Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. RDC Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. RDC Drugs Sales Market Share by Country/Region (2025)
Figure 8. RDC Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global RDC Drugs Market Size Market Share by Target Ligand Types in 2025
Figure 10. Global RDC Drugs Market Size Market Share by Medical Uses in 2025
Figure 11. Global RDC Drugs Market Size Market Share by Therapeutic Radionuclide Properties in 2025
Figure 12. RDC Drugs in Prostate Cancer
Figure 13. Global RDC Drugs Market: Prostate Cancer (2021-2026) & ($ millions)
Figure 14. RDC Drugs in Neuroendocrine Tumors
Figure 15. Global RDC Drugs Market: Neuroendocrine Tumors (2021-2026) & ($ millions)
Figure 16. RDC Drugs in Liver Cancer
Figure 17. Global RDC Drugs Market: Liver Cancer (2021-2026) & ($ millions)
Figure 18. RDC Drugs in Kidney Cancer
Figure 19. Global RDC Drugs Market: Kidney Cancer (2021-2026) & ($ millions)
Figure 20. RDC Drugs in Bone Metastases
Figure 21. Global RDC Drugs Market: Bone Metastases (2021-2026) & ($ millions)
Figure 22. RDC Drugs in Others
Figure 23. Global RDC Drugs Market: Others (2021-2026) & ($ millions)
Figure 24. Global RDC Drugs Market Size Market Share by Application in 2025
Figure 25. Global RDC Drugs Revenue Market Share by Player in 2025
Figure 26. Global RDC Drugs Market Size Market Share by Region (2021-2026)
Figure 27. Americas RDC Drugs Market Size 2021-2026 ($ millions)
Figure 28. APAC RDC Drugs Market Size 2021-2026 ($ millions)
Figure 29. Europe RDC Drugs Market Size 2021-2026 ($ millions)
Figure 30. Middle East & Africa RDC Drugs Market Size 2021-2026 ($ millions)
Figure 31. Americas RDC Drugs Value Market Share by Country in 2025
Figure 32. United States RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. Canada RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Mexico RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. Brazil RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. APAC RDC Drugs Market Size Market Share by Region in 2025
Figure 37. APAC RDC Drugs Market Size Market Share by Target Ligand Types (2021-2026)
Figure 38. APAC RDC Drugs Market Size Market Share by Application (2021-2026)
Figure 39. China RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 40. Japan RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 41. South Korea RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. Southeast Asia RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. India RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. Australia RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. Europe RDC Drugs Market Size Market Share by Country in 2025
Figure 46. Europe RDC Drugs Market Size Market Share by Target Ligand Types (2021-2026)
Figure 47. Europe RDC Drugs Market Size Market Share by Application (2021-2026)
Figure 48. Germany RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 49. France RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. UK RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Italy RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. Russia RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. Middle East & Africa RDC Drugs Market Size Market Share by Region (2021-2026)
Figure 54. Middle East & Africa RDC Drugs Market Size Market Share by Target Ligand Types (2021-2026)
Figure 55. Middle East & Africa RDC Drugs Market Size Market Share by Application (2021-2026)
Figure 56. Egypt RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 57. South Africa RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 58. Israel RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 59. Turkey RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 60. GCC Countries RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 61. Americas RDC Drugs Market Size 2027-2032 ($ millions)
Figure 62. APAC RDC Drugs Market Size 2027-2032 ($ millions)
Figure 63. Europe RDC Drugs Market Size 2027-2032 ($ millions)
Figure 64. Middle East & Africa RDC Drugs Market Size 2027-2032 ($ millions)
Figure 65. United States RDC Drugs Market Size 2027-2032 ($ millions)
Figure 66. Canada RDC Drugs Market Size 2027-2032 ($ millions)
Figure 67. Mexico RDC Drugs Market Size 2027-2032 ($ millions)
Figure 68. Brazil RDC Drugs Market Size 2027-2032 ($ millions)
Figure 69. China RDC Drugs Market Size 2027-2032 ($ millions)
Figure 70. Japan RDC Drugs Market Size 2027-2032 ($ millions)
Figure 71. Korea RDC Drugs Market Size 2027-2032 ($ millions)
Figure 72. Southeast Asia RDC Drugs Market Size 2027-2032 ($ millions)
Figure 73. India RDC Drugs Market Size 2027-2032 ($ millions)
Figure 74. Australia RDC Drugs Market Size 2027-2032 ($ millions)
Figure 75. Germany RDC Drugs Market Size 2027-2032 ($ millions)
Figure 76. France RDC Drugs Market Size 2027-2032 ($ millions)
Figure 77. UK RDC Drugs Market Size 2027-2032 ($ millions)
Figure 78. Italy RDC Drugs Market Size 2027-2032 ($ millions)
Figure 79. Russia RDC Drugs Market Size 2027-2032 ($ millions)
Figure 80. Egypt RDC Drugs Market Size 2027-2032 ($ millions)
Figure 81. South Africa RDC Drugs Market Size 2027-2032 ($ millions)
Figure 82. Israel RDC Drugs Market Size 2027-2032 ($ millions)
Figure 83. Turkey RDC Drugs Market Size 2027-2032 ($ millions)
Figure 84. Global RDC Drugs Market Size Market Share Forecast by Target Ligand Types (2027-2032)
Figure 85. Global RDC Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 86. GCC Countries RDC Drugs Market Size 2027-2032 ($ millions)
Figure 1. RDC Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RDC Drugs Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. RDC Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. RDC Drugs Sales Market Share by Country/Region (2025)
Figure 8. RDC Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global RDC Drugs Market Size Market Share by Target Ligand Types in 2025
Figure 10. Global RDC Drugs Market Size Market Share by Medical Uses in 2025
Figure 11. Global RDC Drugs Market Size Market Share by Therapeutic Radionuclide Properties in 2025
Figure 12. RDC Drugs in Prostate Cancer
Figure 13. Global RDC Drugs Market: Prostate Cancer (2021-2026) & ($ millions)
Figure 14. RDC Drugs in Neuroendocrine Tumors
Figure 15. Global RDC Drugs Market: Neuroendocrine Tumors (2021-2026) & ($ millions)
Figure 16. RDC Drugs in Liver Cancer
Figure 17. Global RDC Drugs Market: Liver Cancer (2021-2026) & ($ millions)
Figure 18. RDC Drugs in Kidney Cancer
Figure 19. Global RDC Drugs Market: Kidney Cancer (2021-2026) & ($ millions)
Figure 20. RDC Drugs in Bone Metastases
Figure 21. Global RDC Drugs Market: Bone Metastases (2021-2026) & ($ millions)
Figure 22. RDC Drugs in Others
Figure 23. Global RDC Drugs Market: Others (2021-2026) & ($ millions)
Figure 24. Global RDC Drugs Market Size Market Share by Application in 2025
Figure 25. Global RDC Drugs Revenue Market Share by Player in 2025
Figure 26. Global RDC Drugs Market Size Market Share by Region (2021-2026)
Figure 27. Americas RDC Drugs Market Size 2021-2026 ($ millions)
Figure 28. APAC RDC Drugs Market Size 2021-2026 ($ millions)
Figure 29. Europe RDC Drugs Market Size 2021-2026 ($ millions)
Figure 30. Middle East & Africa RDC Drugs Market Size 2021-2026 ($ millions)
Figure 31. Americas RDC Drugs Value Market Share by Country in 2025
Figure 32. United States RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 33. Canada RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 34. Mexico RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 35. Brazil RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 36. APAC RDC Drugs Market Size Market Share by Region in 2025
Figure 37. APAC RDC Drugs Market Size Market Share by Target Ligand Types (2021-2026)
Figure 38. APAC RDC Drugs Market Size Market Share by Application (2021-2026)
Figure 39. China RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 40. Japan RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 41. South Korea RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 42. Southeast Asia RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 43. India RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 44. Australia RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 45. Europe RDC Drugs Market Size Market Share by Country in 2025
Figure 46. Europe RDC Drugs Market Size Market Share by Target Ligand Types (2021-2026)
Figure 47. Europe RDC Drugs Market Size Market Share by Application (2021-2026)
Figure 48. Germany RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 49. France RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 50. UK RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 51. Italy RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 52. Russia RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 53. Middle East & Africa RDC Drugs Market Size Market Share by Region (2021-2026)
Figure 54. Middle East & Africa RDC Drugs Market Size Market Share by Target Ligand Types (2021-2026)
Figure 55. Middle East & Africa RDC Drugs Market Size Market Share by Application (2021-2026)
Figure 56. Egypt RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 57. South Africa RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 58. Israel RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 59. Turkey RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 60. GCC Countries RDC Drugs Market Size Growth 2021-2026 ($ millions)
Figure 61. Americas RDC Drugs Market Size 2027-2032 ($ millions)
Figure 62. APAC RDC Drugs Market Size 2027-2032 ($ millions)
Figure 63. Europe RDC Drugs Market Size 2027-2032 ($ millions)
Figure 64. Middle East & Africa RDC Drugs Market Size 2027-2032 ($ millions)
Figure 65. United States RDC Drugs Market Size 2027-2032 ($ millions)
Figure 66. Canada RDC Drugs Market Size 2027-2032 ($ millions)
Figure 67. Mexico RDC Drugs Market Size 2027-2032 ($ millions)
Figure 68. Brazil RDC Drugs Market Size 2027-2032 ($ millions)
Figure 69. China RDC Drugs Market Size 2027-2032 ($ millions)
Figure 70. Japan RDC Drugs Market Size 2027-2032 ($ millions)
Figure 71. Korea RDC Drugs Market Size 2027-2032 ($ millions)
Figure 72. Southeast Asia RDC Drugs Market Size 2027-2032 ($ millions)
Figure 73. India RDC Drugs Market Size 2027-2032 ($ millions)
Figure 74. Australia RDC Drugs Market Size 2027-2032 ($ millions)
Figure 75. Germany RDC Drugs Market Size 2027-2032 ($ millions)
Figure 76. France RDC Drugs Market Size 2027-2032 ($ millions)
Figure 77. UK RDC Drugs Market Size 2027-2032 ($ millions)
Figure 78. Italy RDC Drugs Market Size 2027-2032 ($ millions)
Figure 79. Russia RDC Drugs Market Size 2027-2032 ($ millions)
Figure 80. Egypt RDC Drugs Market Size 2027-2032 ($ millions)
Figure 81. South Africa RDC Drugs Market Size 2027-2032 ($ millions)
Figure 82. Israel RDC Drugs Market Size 2027-2032 ($ millions)
Figure 83. Turkey RDC Drugs Market Size 2027-2032 ($ millions)
Figure 84. Global RDC Drugs Market Size Market Share Forecast by Target Ligand Types (2027-2032)
Figure 85. Global RDC Drugs Market Size Market Share Forecast by Application (2027-2032)
Figure 86. GCC Countries RDC Drugs Market Size 2027-2032 ($ millions)
